Explore all the latest information in
acute myeloid leukemia
, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
AACR 2020 | Can we use CH assessment to predict the risk of therapy-related myeloid neoplasms?
The AML Hub was pleased to speak to Kelly Bolton, Memorial Sloan Kettering Cancer Center, New York, US,...
AACR 2020 | Patients with altered TP53 R/R AML have increased tumor immune-infiltration and show sensitivity to flotetuzumab
During the AACR Virtual Annual Meeting I 2020, Sergio Rutella, presented...
Summary of TCT 2020 highlights – part 2: Transplant outcomes in patients with adverse risk AML
This article is based on an overview of the International Academy for Clinical Hematology webinar...
Summary of TCT 2020 highlights – part 1: Conditioning regimens for AML and MDS
This article is based on an overview of the International Academy for Clinical Hematology webinar delivered by Bipin...
Molecular MRD status as a predictor of outcome in patients with NPM1-mutated acute myeloid leukemia (AML)
Measurable residual disease (MRD) assessed prior to allogeneic hematopoietic stem cell...
AML Hub Symposium | How does MRD impact outcome of stem cell transplantation in AML – now and in the future?
At the 46th annual meeting of the European Society for Blood and Marrow Transplantation the...
Interim phase II results from the ongoing AG221-AML-005 study on enasidenib plus azacitidine in patients with newly diagnosed acute myeloid leukemia with IDH2 mutations
Enasidenib (ENA) is an oral,...
Impact of gene mutations on the efficacy of CPX-351 versus 7+3 in older patients with newly diagnosed, high-risk/secondary acute myeloid leukemia
In newly diagnosed AML, risk stratification relies...
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
European Hematology Association
European School of Haematology
European Society for Blood and Marrow Transplantation
International Symposium on Acute Leukemias
National Cancer Research Institute
NCRI AML Academy 2019
ASTCT and CIBMTR TCT Meeting 2020
EHA–EBMT CAR T Meeting 2020
Society of Hematologic Oncology